drugset / Trial / NCT07245628

A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy

NCT07245628

Phase 0 Recruiting 50 enrolled Alexandra J. Berger Eberhardt, MD
RandomizedParallel-groupSingle-blindSupportive care

Summary

The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting. This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy. The main questions it aims to answer are: * Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy. * To examine whether SANO reduces intraoperative pain or alters procedure duration, the rate of adverse events, or urologists' perception of ease and patient tolerance of the procedure. Participants will be asked to complete multiple surveys pre-procedure, intra-procedure, and post-procedure.

Timeline

Start
2025-10-20
Primary completion
2028-05-01
Completion
2030-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified 20 %
Subject Nitrous Oxide Other / unclassified 45 %

Indications

No indication recorded.